Diarrhea: When to See a Doctor and What Causes It

What Counts as Diarrhea and Why Does It Happen?

The World Health Organization defines diarrhea as passing three or more loose or watery stools within a 24-hour period [1]. A single soft bowel movement after a rich meal does not qualify. The distinction matters because true diarrhea signals that your gut is either secreting excess fluid, failing to absorb fluid, or moving contents through too quickly for normal water reabsorption.

The gastrointestinal tract processes roughly 9 liters of fluid daily. About 7 liters come from digestive secretions (saliva, gastric juice, bile, pancreatic fluid), while 2 liters come from oral intake. The colon normally absorbs all but 100 to 200 mL of that total volume [2]. When pathogens, toxins, inflammatory mediators, or osmotically active substances disrupt this balance, stool water content rises above 75% and diarrhea results.

Four pathophysiologic mechanisms drive most cases: secretory (cholera toxin, for example, forces chloride channels open), osmotic (undigested lactose pulls water into the lumen), inflammatory (mucosal damage from Crohn's disease or infection), and motility-related (irritable bowel syndrome with diarrhea, or IBS-D). A single episode can involve more than one mechanism. Sorting out which one dominates guides treatment, which is why a careful history often matters more than reflexively ordering a stool panel.

Common Causes of Acute Diarrhea

Viral gastroenteritis accounts for the majority of acute diarrhea in adults. Norovirus alone causes 685 million cases worldwide each year, according to CDC surveillance data [3]. Rotavirus remains a leading cause in unvaccinated children. These infections are self-limited, typically resolving in one to three days without specific therapy.

Bacterial pathogens account for a smaller but clinically significant share. Campylobacter, Salmonella, Shigella, and enterotoxigenic E. coli are the most frequent culprits identified on stool culture. A 2018 analysis published in The Lancet Infectious Diseases estimated that bacterial enteric infections cause approximately 600,000 deaths per year globally, with the highest burden in sub-Saharan Africa and South Asia [4]. Foodborne outbreaks in the United States are most commonly linked to Salmonella and Campylobacter, per CDC FoodNet data [3].

Medications are an underrecognized trigger. Antibiotics cause diarrhea in 5% to 39% of courses, depending on the agent [5]. Metformin, SSRIs, proton pump inhibitors, NSAIDs, and magnesium-containing antacids are other frequent offenders. Drug-induced diarrhea typically begins within days of starting the medication and resolves after discontinuation.

Traveler's diarrhea deserves separate mention. It affects 30% to 70% of travelers to high-risk regions, with enterotoxigenic E. coli (ETEC) responsible for roughly half of cases [6]. The American College of Gastroenterology (ACG) guideline recommends bismuth subsalicylate for prophylaxis and single-dose azithromycin or fluoroquinolone for moderate-to-severe episodes [7].

When to See a Doctor: Red Flags You Should Not Ignore

Seek medical evaluation within 24 hours if any of these signs appear: blood or pus in the stool, fever at or above 102 °F (38.9 °C), severe abdominal or rectal pain, six or more unformed stools per day, or symptoms of dehydration (dry mucous membranes, decreased urine output, orthostatic dizziness) [7]. These are not arbitrary thresholds. They correlate with conditions that require targeted therapy rather than watchful waiting.

Bloody diarrhea narrows the differential to a handful of diagnoses that can worsen rapidly. Shigella, enterohemorrhagic E. coli (including O157:H7), Clostridioides difficile, inflammatory bowel disease (IBD), and ischemic colitis all produce hematochezia. The ACG practice guideline states: "Bloody diarrhea warrants stool studies and, depending on clinical context, endoscopic evaluation" [7].

Certain populations need a lower threshold for seeking care. Adults over 65 face higher rates of C. difficile infection and are more vulnerable to dehydration-related complications, including acute kidney injury. The CDC reports that C. difficile causes approximately 223,900 infections requiring hospitalization and 12,800 deaths annually in the United States, with adults 65 and older accounting for 82% of those deaths [8]. Immunocompromised patients (HIV, chemotherapy, organ transplant recipients) can develop severe or opportunistic infections that mimic routine gastroenteritis. Pregnant individuals should seek care early because dehydration can reduce uterine perfusion and trigger preterm contractions.

Go to the emergency department if you cannot keep any fluids down for more than 12 hours, have a heart rate above 100 beats per minute at rest, feel confused or lightheaded when standing, or pass bloody stool in large volume. These findings suggest hemodynamic compromise that requires intravenous fluid resuscitation.

Chronic Diarrhea: When It Lasts Longer Than Four Weeks

Chronic diarrhea affects roughly 5% of the U.S. population at any given time [9]. Its causes differ fundamentally from acute diarrhea. The most common include IBS-D, inflammatory bowel disease (Crohn's disease and ulcerative colitis), celiac disease, microscopic colitis, bile acid malabsorption, small intestinal bacterial overgrowth (SIBO), chronic infections (especially in immunocompromised hosts), and endocrine disorders such as hyperthyroidism.

IBS-D is the single most frequent diagnosis, accounting for 25% to 50% of gastroenterology referrals for chronic diarrhea in Western countries [10]. Diagnosis relies on the Rome IV criteria: recurrent abdominal pain at least one day per week for three months, associated with defecation, a change in stool frequency, or a change in stool form. No single biomarker confirms IBS, but checking fecal calprotectin can help distinguish it from IBD. A calprotectin level below 50 µg/g has a negative predictive value above 95% for ruling out active IBD [11].

Celiac disease deserves routine consideration. The ACG guideline recommends serologic screening with tissue transglutaminase IgA (tTG-IgA) in all patients with chronic diarrhea, because celiac disease affects approximately 1% of the population and is underdiagnosed [12]. Dr. Peter Green, director of the Celiac Disease Center at Columbia University, has noted: "The average time to diagnosis of celiac disease in the United States remains 6 to 10 years from symptom onset, largely because clinicians do not think to test for it."

Bile acid malabsorption (BAM) is another frequently missed cause. It may account for up to one-third of patients previously diagnosed with IBS-D. The SeHCAT test is the gold standard for diagnosis in Europe, though it is unavailable in the U.S., where an empiric trial of cholestyramine (4 g twice daily) serves as both diagnostic and therapeutic [13].

How Diarrhea Is Diagnosed

The diagnostic approach depends on duration, severity, and clinical context. Acute, mild, non-bloody diarrhea in an otherwise healthy adult typically requires no testing at all. Most guidelines recommend supportive care and reassessment if symptoms persist beyond 48 to 72 hours [7].

When testing is warranted, the initial workup generally includes a stool culture for bacterial pathogens, a C. difficile toxin assay (particularly after recent antibiotic use or hospitalization), and examination for ova and parasites if travel history or immunosuppression is present. Multiplex PCR stool panels (such as the BioFire FilmArray GI panel) can detect 22 pathogens simultaneously and return results within one hour, though their high sensitivity means they sometimes identify organisms that are not causing the current illness [14].

For chronic diarrhea, the workup broadens. Standard blood tests include a complete blood count, comprehensive metabolic panel, thyroid function, C-reactive protein, and celiac serologies (tTG-IgA). Fecal calprotectin or lactoferrin helps stratify inflammatory versus functional etiologies. Colonoscopy with random biopsies is indicated when IBD or microscopic colitis is suspected, because microscopic colitis produces a grossly normal-appearing mucosa that only reveals inflammation on histology [15].

The 2019 British Society of Gastroenterology guideline for chronic diarrhea investigation states: "All patients with chronic diarrhea should have baseline blood tests including full blood count, urea and electrolytes, C-reactive protein, celiac serology, and thyroid function, with stool tests for infection and inflammation" [16]. This systematic approach prevents the common pitfall of jumping to colonoscopy before excluding simpler diagnoses.

Treatment for Acute Diarrhea

Oral rehydration is the foundation. The WHO oral rehydration solution (ORS), containing 75 mmol/L sodium, 75 mmol/L glucose, 65 mmol/L chloride, 20 mmol/L potassium, and 10 mmol/L citrate, remains the single most effective intervention for diarrheal dehydration. A Cochrane review of 15 randomized trials confirmed that reduced-osmolarity ORS decreases stool output and the need for intravenous fluids compared with the original WHO formula [17]. Commercial options like Pedialyte or Drip Drop approximate this composition. Sports drinks contain too much sugar and too little sodium for effective rehydration during significant diarrhea.

Loperamide (Imodium) is the primary antimotility agent. It works by activating mu-opioid receptors in the intestinal wall, slowing peristalsis and increasing fluid absorption. The standard adult dose is 4 mg initially, then 2 mg after each unformed stool, not exceeding 16 mg per day. Loperamide is safe for most adults with non-bloody, non-febrile diarrhea but should be avoided in suspected C. difficile infection, dysenteric illness, or children under 2 years of age [7].

Bismuth subsalicylate (Pepto-Bismol) reduces stool frequency by approximately 50% in traveler's diarrhea and has mild antibacterial and antisecretory properties [6]. The typical dose is 524 mg every 30 to 60 minutes as needed, up to 8 doses in 24 hours.

Antibiotics are not routine for acute diarrhea. The ACG guideline reserves empiric antibiotic therapy for moderate-to-severe traveler's diarrhea (azithromycin 1 to 000 mg single dose or 500 mg daily for three days), suspected or confirmed C. difficile (oral vancomycin 125 mg four times daily for 10 days as first-line per IDSA/SHEA 2021 guidance), and immunocompromised patients with febrile diarrhea [7][18]. Antibiotic use in uncomplicated Salmonella gastroenteritis may prolong the carrier state and is not recommended for otherwise healthy adults.

Probiotics have modest evidence for specific indications. Saccharomyces boulardii reduced antibiotic-associated diarrhea by 51% in a meta-analysis of 21 randomized trials (RR 0.49 to 95% CI 0.38 to 0.63) [19]. For acute infectious diarrhea, the benefit is smaller. The large PLACIDE trial (N=2,981) found no significant benefit of Lactobacillus and Bifidobacterium preparations for C. difficile-associated diarrhea prevention in older hospitalized patients [20].

Managing Chronic Diarrhea

Treatment targets the underlying cause. IBS-D responds to dietary modification (low-FODMAP diet reduces symptoms in 50% to 80% of patients in short-term trials), loperamide for symptom control, and prescription agents when first-line measures fail [10]. Eluxadoline (Viberzi) 100 mg twice daily reduced the composite endpoint of abdominal pain and stool consistency in the phase III trials (IBS-3001 and IBS-3002, combined N=2,427), with 26% to 33% of patients meeting the primary responder endpoint versus 17% to 20% on placebo [21]. Rifaximin 550 mg three times daily for 14 days is FDA-approved for IBS-D and showed sustained benefit in 36% of patients versus 21% on placebo in the TARGET 3 trial [22].

Bile acid malabsorption responds well to bile acid sequestrants. Cholestyramine, colestipol, and colesevelam all reduce stool frequency and urgency. Colesevelam (Welchol) 625 mg tablets, three tablets twice daily, tends to be better tolerated than cholestyramine due to fewer gastrointestinal side effects and tablet formulation.

Inflammatory bowel disease requires disease-specific therapy: 5-aminosalicylates for mild-to-moderate ulcerative colitis, corticosteroids for flares, and biologic agents (infliximab, adalimumab, vedolizumab, ustekinumab) for moderate-to-severe disease. Celiac disease mandates a strict, lifelong gluten-free diet, which resolves symptoms in 70% to 80% of patients within weeks to months [12].

Microscopic colitis, often triggered by NSAIDs or PPIs, responds to budesonide 9 mg daily, tapered over 8 to 12 weeks. A Cochrane review found budesonide induced clinical remission in 81% of patients with collagenous colitis versus 30% on placebo [23].

Preventing Diarrhea and Dehydration

Hand hygiene is the most effective prevention measure. A meta-analysis published in The Lancet Infectious Diseases showed that handwashing with soap reduced the incidence of diarrheal disease by 42% to 47% in community settings [24]. Alcohol-based hand sanitizers are effective against most bacteria and some viruses but do not kill norovirus or C. difficile spores, which require soap and water.

Food safety practices prevent most bacterial diarrhea. Cook meats to safe internal temperatures (165 °F for poultry, 160 °F for ground beef). Refrigerate leftovers within two hours. Avoid unpasteurized dairy and raw shellfish, particularly during warmer months when Vibrio species proliferate.

For travelers, the CDC recommends drinking only bottled or boiled water and avoiding raw vegetables, unpeeled fruits, and ice in high-risk regions [3]. Bismuth subsalicylate 524 mg four times daily provides approximately 65% protection against traveler's diarrhea, though the convenience of carrying and dosing limits its practical use for long trips [6].

Rotavirus vaccination (RotaTeq or Rotarix) has reduced rotavirus-associated hospitalizations in U.S. children by 85% to 94% since its introduction in 2006 [25]. Adults benefit indirectly through reduced community transmission.

Patients taking antibiotics can reduce the risk of antibiotic-associated diarrhea with S. boulardii 250 mg twice daily, started on the first day of antibiotic therapy and continued for the duration of the course plus one week after completion [19].